CellSync (H10x)
Shaping the Future of Cell Engineering | cellsyncbiosciences.com
CellSync Biosciences is revolutionising gene delivery and cell engineering. Our approach aims to improve quality of care for cancer patients and is faster, safer, and more affordable. We’re dedicated to utilizing our cutting-edge technology for highly efficient engineering of immune cells to produce smarter and stronger immune cells to fight against cancer cells. Our mission is to improve not only the quality of care, but the quality of life for cancer patients and we are passionate about driving advancements in this critical area.
Team members
Dr. Dorsa Rad, Co-Founder & CEO
Prof. Majid E. Warkiani, Co-Founder
Achievements
The recipient of the UTS Techcelerator program award and a Sydney Vital Grant
Initiated three collaborations with Key Opinion Leaders (KOLs)
Commenced manufacturing discussions with TTP in the UK.